MPA Press Releases


MPA Press Releases

News releases from MPA sent to members of the media.

PBM Reform Advancing in Michigan with House Passage of HB 4348

NCPA, MPA urge Senate, Gov. Whitmer to swiftly finalize state’s first PBM regulation

LANSING, Mich. (March 24, 2021) — The Michigan Pharmacists Association and the National Community Pharmacists Association applaud passage of Michigan House Bill 4348 by the state’s House of Representatives in a vote of 97-10. This legislation, introduced by Rep. Julie Calley, would provide much-needed pharmacy benefit manager reforms, which are lacking in Michigan. PBMs are threatening access to community pharmacies and increasing health care costs for patients and plan sponsors in Michigan. The bill had passed the Health Policy Committee, chaired by Rep. Bronna Kahle, in a vote of 18-1, and now heads to the Senate for consideration.

“PBMs, which dictate how patients get their prescriptions and how much they pay, spent years operating in the shadows and manipulating the complicated health care system to fleece patients, taxpayers, and pharmacies,” said MPA CEO Mark Glasper. “Thankfully, their tactics are being uncovered and restricted in states across the country. Michigan must rein them in too.

“House Speaker Jason Wentworth was a driving force behind this legislation,” Glasper said. “MPA has been educating and working with the speaker for the past four years on the tactics that PBMs use in his state and across the country. His leadership and the strong support of the Michigan House of Representatives for HB 4348 have been integral to the bill’s passage. The Senate and Gov. Whitmer should quickly approve House Bill 4348 to provide patients and local pharmacies with the relief they need.”

House Bill 4348 would prohibit PBMs from reimbursing pharmacies affiliated with the PBM more than non-affiliate pharmacies; prohibit patient steering to PBM-owned pharmacies; prohibit retroactive clawbacks; require reimbursements be based on the National Average Drug Acquisition Cost, an objective benchmark that accurately reflects the true market costs for Michigan pharmacies; and establish fair audit procedures for community pharmacies.

“The majority of states have laws on the books to curb drug costs by regulating PBMs, whether by outlawing patient steering, requiring the PBM to be licensed by the state, banning gag clauses or through other reforms,” said Anne Cassity, NCPA Vice President of Federal and State Government Affairs. “Independent neighborhood pharmacies and their patients are eager to see Michigan implement PBM regulations as well. We’re grateful to Reps. Calley and Kahle, to Speaker Wentworth, and to their colleagues for joining them in supporting this important legislation.”

Click here for NCPA's letter in support of House Bill 4348.

Posted in: MPA Press Releases
MPA Applauds PBM Reform Introduced in State Legislature

(Lansing, Mich.) – A bill to reform unreasonable practices by pharmacy benefit managers (PBMs) – long-advocated for by the Michigan Pharmacists Association (MPA) – was introduced today in the Michigan Legislature as part of a 15-bill package aimed at lowering the cost of prescription drugs.

House Bill 4348, introduced by Rep. Julie Calley (R-Portland), is designed to reign in PBMs by requiring them to register with the state, addressing transaction fees and prohibiting clawbacks. It also codifies the U.S. Supreme Court’s recent decision in Arkansas v. PCMA (Pharmaceutical Care Management Association), which requires PBMs to reimburse pharmacies at no less than the cost of the drug.

To read the press release, click here.

Posted in: MPA Press Releases
Michigan Pharmacists Association Welcomes Mark Glasper As New Chief Executive Officer

FOR IMMEDIATE RELEASE Wednesday, Jan. 20, 2021
Contact: Mary Beth Wardell, MPA communications manager
Phone: (517) 377-0232
Email: Communication@MichiganPharmacists.org

Michigan Pharmacists Association Welcomes Mark Glasper As New Chief Executive Officer

(Lansing, Mich.) – Mark Glasper has joined the Michigan Pharmacists Association as its chief executive officer, following the retirement of Larry Wagenknecht on Friday. Glasper is the former executive director and CEO of the Kentucky Pharmacists Association (KPhA).

As one of the most respected state pharmacy associations in the country, Glasper said he is honored by the opportunity to serve MPA and achieve the goals and vision laid out by its members.

"I am truly honored and humbled to take on this role,” Glasper said. “I look forward to utilizing my pharmacy knowledge and lifelong association management experience to build on MPA’s past successes and take the organization to greater heights on behalf of our dedicated members throughout the great state of Michigan.”

The MPA Executive Board selected Glasper in October following a nationwide search. Board Chair Charlie Mollien said the board is pleased to have someone of Glasper’s experience and caliber to lead the MPA.

“Mark brings proven strategies and an impressive record of achievements to this role,” Mollien said. “The Executive Board noted his successful lobbying efforts in Kentucky and his clear passion for serving members. Out of a field of remarkable candidates, it became clear to the board that Mark stood out from the pack.”

Glasper graduated from The Ohio State University with a Bachelor of Arts degree in Journalism – Public Relations. He serves on the nominating and planning committees of the National Alliance of State Pharmacy Associations; the board of directors for the Alliance for Patient Medication Safety, and previously served as executive director of the Ohio Society of Association Executives.

"Mark brings true professionalism to this role, with a strong knowledge of pharmacy-related issues,” Wagenknecht said. “When I came to work for MPA, it was with the desire to make a difference – to improve the profession. While there have been successes, there is still much more to do. I am proud and thankful to have been part of an excellent team of pharmacists, staff and dedicated members over the past 37 years. As I retire, I know the organization is in capable hands as it continues to advance pharmacy into the future.”

Since 1983, Wagenknecht served in several roles at MPA and as CEO since 1994. Wagenknecht has been a champion for the profession and instituted changes that include the creation and growth of the Michigan Health Professional Recovery Corporation, MPA Executive Fellowship program, Pharmacy Technician Certification Board (PTCB) and the Michigan Health Information Network (MiHIN).

"It’s an honor to follow in the footsteps of such an accomplished leader as Larry Wagenknecht,” Glasper said. “I’m grateful to him for his many contributions to the organization, as well as for his mentorship and support throughout this transition.”

Michigan Pharmacists Association strives to serve members by providing support, advocacy and resources that ultimately improve patient care, safety, health and the practice of pharmacy. For more information, visit www.MichiganPharmacists.org

Posted in: MPA Press Releases
MSHP Professional Practice Award

FOR IMMEDIATE RELEASE
Oct. 27, 2016
Contact: Kristina Bird, communications manager
(517) 377-0232

 

Professional Practice Award given to Dorsch for Involvement in New Adherence Approaches

 

Lansing, Mich. – Michael Dorsch, Pharm.D., M.S., FCCP, BCPS (AQCV), will receive the 2016 Michigan Society of Health-System Pharmacists (MSHP) Professional Practice Award at this year’s MSHP Annual Meeting on Oct. 28.

 

The MSHP Professional Practice Award recognizes and honors a pharmacist or organization for involvement and participation in an innovative project (e.g., published research, projects or services implemented) that contributes to professional practice. This year’s recipient is being honored for his work supporting the mission of the American Heart Association (AHA) to build healthier lives that are free of cardiovascular disease and stroke. More specifically, Dr. Dorsch has developed a mobile application for heart failure patients, ManageHF, aimed at educating patients in order to increase the adherence and efficacy of recommended treatments for cardiovascular diseases.

 

Michael Dorsch currently has over 40 peer-reviewed publications, one book and has conducted over 18 national presentations. In 2011, Dr. Dorsch received the Top Paper Award for Population Science at the AHA Council for High Blood Pressure Research Conference. In this paper Dr. Dorsch demonstrated the superior efficacy of chlorthalidone in reducing cardiovascular events in hypertension and this discovery was ultimately included in the European Society of Cardiology (ESC) Hypertension guidelines. Currently, the Agency for Healthcare Research and Quality (AHRQ) is funding Dr. Dorsch’s work to create a mobile application to assist patients in making better and more informed decisions while shopping at the grocery store and dining out while adhering to a low sodium diet. The National Institutes of Health (NIH) has also supported Dr. Dorsch in creating technology to increase self-monitoring and self-management of heart failure patients, increasing adherence to diet restriction for hypertension patients and an automated home medication dispensing machine.

 

Dr. Dorsch currently works as a clinical associate professor at the University of Michigan (UM) College of Pharmacy and is also a clinical pharmacist in cardiology at the Department of Pharmacy Services UM Health System, Ann Arbor, Mich. In this position, Dr. Dorsch provides inpatient pharmacy services to cardiology patients at the UM Frankel Cardiovascular Center as well as coordinating cardiology courses at the UM College of Pharmacy. Dr. Dorsch is also a site preceptor for the American College of Clinical Pharmacy (ACCP) HF Traineeship and created the Post-Graduate Year 2 Cardiology Residency Program at UM in 2008 and has been serving as the director ever since. Dr. Dorsch has dedicated his life to educating patients and empowering them to make the best decisions for their health.

 

MSHP is a practice section of MPA consisting of more than 600 health-system pharmacy professionals. Since its founding in 1883, MPA has been a leader in the professional and scientific advancement of pharmacy and in safeguarding the well-being of individual patients in Michigan.

 

###

Posted in: MPA Press Releases
MSHP President's Award

FOR IMMEDIATE RELEASE
Oct. 27, 2016
Contact: Kristina Bird, communications manager
(517) 377-0232

 

Hae Mi Choe presented with President’s Award for

Innovative Practice Model Implementation

Lansing, Mich. – Hae Mi Choe, Pharm.D. will be honored with this year’s Michigan Society of Health-System Pharmacists (MSHP) President’s Award at the 2016 MSHP Annual Meeting on Oct. 28.

The MSHP President’s Award recognizes the commitment of a pharmacy professional or a pharmacy organization to advancing the theme and goal of the MSHP Board of Directors throughout the year. This year, MSHP has focused on provider status and the concept of “Changing Gears.” As the terrain of pharmacy continues to shift, and the direction of the profession heads toward new frontiers, Hae Mi Choe has established herself as a pioneer in her work to advance the role of pharmacists in the ambulatory care setting. Dr. Choe is recognized by her colleagues as an incredible innovator as well as a strong supporter through hands on assistance and mentorship of colleagues advancing their practice. They also note she is kind, organized and approachable. Consistent with this year’s theme, the work Dr. Choe has done, and continues to do, creates a framework for pharmacists to practice as providers to improve the overall care of patients. It also serves as an inspiration and model for future pharmacists to practice in these advanced roles.

Dr. Choe received her baccalaureate degree in Biochemistry/Cell Biology from the University of California, San Diego and her Doctor of Pharmacy degree from the University of California, San Francisco. She completed her Pharmacy Practice Residency at Kaiser Permanente in Los Angeles. After residency, she moved to Seoul, South Korea, and developed and implemented anticoagulation and asthma services at the Samsung Medical Center. After five years overseas, Dr. Choe joined the faculty at the University of Michigan Health System (UMHS) to develop ambulatory clinical services. In 2009, Dr. Choe was promoted to the position of Director of Innovative Ambulatory Care Pharmacy Practices at UMHS. In this role, she created a group practice model at UMHS as part of the Patient Centered Medical Home across 14 health centers, as well as a new reimbursement process for clinical pharmacy services. She was the first pharmacist evaluated and endorsed by the Credentialing Committee at UMHS and was granted special privileges in patient care; she has since led her entire team of clinical pharmacists through the credentialing process. Dr. Choe has been recognized numerous times throughout her career for both her excellence in teaching as well as for her work in developing innovative practice models. Notably, in 2011 she and her colleagues were awarded both the MPA Innovative Pharmacy Practice Award and the ASHP Best Practice Award for their group practice model in the Patient-Centered Medical Home. In 2014, Dr. Choe received the American Pharmacists Association (APhA) Pinnacle Award in the Individual Career Achievement category.

As part of her current role, Dr. Choe has been instrumental in the development and launch of the Michigan Pharmacists Transforming Care and Quality (MPTCQ) Collaborative Process Initiative (CPI) program, a collaboration between Blue Cross and Blue Shield of Michigan (BCBSM) and UMHS which aims to integrate clinical pharmacists into more direct patient care roles. This program, which was modeled after the program Dr. Choe built at UMHS, has brought clinical pharmacy services to 17 health-system or physician group practices throughout the state, which encompasses over 50 individual practice sites, all with a goal of improving patient care through pharmacist-physician collaboration. The program continues to expand, with the intent to implement it in all 46 health-system or physician group practices that work with BCBSM over the next several years.

 

MSHP is a practice section of the Michigan Pharmacists Association consisting of more than 600 health-system pharmacy professionals. Since its founding in 1883, MPA has been a leader in the professional and scientific advancement of pharmacy and in safeguarding the well-being of individual patients in Michigan.

 

###

Posted in: MPA Press Releases
Page 1 of 6First   Previous   [1]  2  3  4  5  6  Next   Last